H2B2F_HUMAN - dbPTM
H2B2F_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID H2B2F_HUMAN
UniProt AC Q5QNW6
Protein Name Histone H2B type 2-F
Gene Name HIST2H2BF
Organism Homo sapiens (Human).
Sequence Length 126
Subcellular Localization Nucleus. Chromosome.
Protein Description Core component of nucleosome. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling..
Protein Sequence MPDPAKSAPAPKKGSKKAVTKVQKKDGKKRKRSRKESYSVYVYKVLKQVHPDTGISSKAMGIMNSFVNDIFERIAGEASRLAHYNKRSTITSREIQTAVRLLLPGELAKHAVSEGTKAVTKYTSSK
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MPDPAKSAP
------CCCHHHCCC
57.18-
6N6-crotonyl-L-lysine--MPDPAKSAPAPKK
--CCCHHHCCCCCCC
53.17-
6Acetylation--MPDPAKSAPAPKK
--CCCHHHCCCCCCC
53.1719608861
6Butyrylation--MPDPAKSAPAPKK
--CCCHHHCCCCCCC
53.1727105113
6Crotonylation--MPDPAKSAPAPKK
--CCCHHHCCCCCCC
53.1721925322
6Lactoylation--MPDPAKSAPAPKK
--CCCHHHCCCCCCC
53.1731645732
6Other--MPDPAKSAPAPKK
--CCCHHHCCCCCCC
53.1727105115
6Sumoylation--MPDPAKSAPAPKK
--CCCHHHCCCCCCC
53.1719608861
6Ubiquitination--MPDPAKSAPAPKK
--CCCHHHCCCCCCC
53.1733845483
7Phosphorylation-MPDPAKSAPAPKKG
-CCCHHHCCCCCCCC
41.4123403867
12N6-crotonyl-L-lysineAKSAPAPKKGSKKAV
HHCCCCCCCCCCHHH
72.39-
12AcetylationAKSAPAPKKGSKKAV
HHCCCCCCCCCCHHH
72.39158409
12CrotonylationAKSAPAPKKGSKKAV
HHCCCCCCCCCCHHH
72.3921925322
12LactoylationAKSAPAPKKGSKKAV
HHCCCCCCCCCCHHH
72.3931645732
12LactylationAKSAPAPKKGSKKAV
HHCCCCCCCCCCHHH
72.3931645732
12OtherAKSAPAPKKGSKKAV
HHCCCCCCCCCCHHH
72.3927105115
12UbiquitinationAKSAPAPKKGSKKAV
HHCCCCCCCCCCHHH
72.3925015289
13N6-crotonyl-L-lysineKSAPAPKKGSKKAVT
HCCCCCCCCCCHHHH
68.32-
13AcetylationKSAPAPKKGSKKAVT
HCCCCCCCCCCHHHH
68.3219608861
13CrotonylationKSAPAPKKGSKKAVT
HCCCCCCCCCCHHHH
68.3221925322
13OtherKSAPAPKKGSKKAVT
HCCCCCCCCCCHHHH
68.3224681537
15PhosphorylationAPAPKKGSKKAVTKV
CCCCCCCCCHHHHHH
39.6012757711
16N6-crotonyl-L-lysinePAPKKGSKKAVTKVQ
CCCCCCCCHHHHHHH
54.11-
16AcetylationPAPKKGSKKAVTKVQ
CCCCCCCCHHHHHHH
54.1119608861
16CrotonylationPAPKKGSKKAVTKVQ
CCCCCCCCHHHHHHH
54.1121925322
16LactoylationPAPKKGSKKAVTKVQ
CCCCCCCCHHHHHHH
54.1131645732
17N6-crotonyl-L-lysineAPKKGSKKAVTKVQK
CCCCCCCHHHHHHHH
50.19-
17AcetylationAPKKGSKKAVTKVQK
CCCCCCCHHHHHHHH
50.1919608861
17CrotonylationAPKKGSKKAVTKVQK
CCCCCCCHHHHHHHH
50.1921925322
17GlutarylationAPKKGSKKAVTKVQK
CCCCCCCHHHHHHHH
50.1931542297
17LactoylationAPKKGSKKAVTKVQK
CCCCCCCHHHHHHHH
50.1931645732
17LactylationAPKKGSKKAVTKVQK
CCCCCCCHHHHHHHH
50.1931645732
17OtherAPKKGSKKAVTKVQK
CCCCCCCHHHHHHHH
50.1927105115
21N6-crotonyl-L-lysineGSKKAVTKVQKKDGK
CCCHHHHHHHHCCCC
35.75-
21AcetylationGSKKAVTKVQKKDGK
CCCHHHHHHHHCCCC
35.7519608861
21ButyrylationGSKKAVTKVQKKDGK
CCCHHHHHHHHCCCC
35.7527105113
21CrotonylationGSKKAVTKVQKKDGK
CCCHHHHHHHHCCCC
35.7521925322
21LactoylationGSKKAVTKVQKKDGK
CCCHHHHHHHHCCCC
35.7531645732
21LactylationGSKKAVTKVQKKDGK
CCCHHHHHHHHCCCC
35.7531645732
21OtherGSKKAVTKVQKKDGK
CCCHHHHHHHHCCCC
35.7527105115
21SumoylationGSKKAVTKVQKKDGK
CCCHHHHHHHHCCCC
35.7528112733
21UbiquitinationGSKKAVTKVQKKDGK
CCCHHHHHHHHCCCC
35.7533845483
24N6-crotonyl-L-lysineKAVTKVQKKDGKKRK
HHHHHHHHCCCCCCC
56.68-
24AcetylationKAVTKVQKKDGKKRK
HHHHHHHHCCCCCCC
56.6823749302
24CrotonylationKAVTKVQKKDGKKRK
HHHHHHHHCCCCCCC
56.6821925322
24LactoylationKAVTKVQKKDGKKRK
HHHHHHHHCCCCCCC
56.6831645732
24LactylationKAVTKVQKKDGKKRK
HHHHHHHHCCCCCCC
56.6831645732
24OtherKAVTKVQKKDGKKRK
HHHHHHHHCCCCCCC
56.6824681537
25AcetylationAVTKVQKKDGKKRKR
HHHHHHHCCCCCCCC
55.4012635587
25OtherAVTKVQKKDGKKRKR
HHHHHHHCCCCCCCC
55.4024681537
29UbiquitinationVQKKDGKKRKRSRKE
HHHCCCCCCCCCCHH
69.5423000965
31UbiquitinationKKDGKKRKRSRKESY
HCCCCCCCCCCHHHH
64.7023000965
33PhosphorylationDGKKRKRSRKESYSV
CCCCCCCCCHHHHHH
51.2228152594
35UbiquitinationKKRKRSRKESYSVYV
CCCCCCCHHHHHHHH
52.8621890473
35N6-crotonyl-L-lysineKKRKRSRKESYSVYV
CCCCCCCHHHHHHHH
52.86-
35AcetylationKKRKRSRKESYSVYV
CCCCCCCHHHHHHHH
52.8619608861
35CrotonylationKKRKRSRKESYSVYV
CCCCCCCHHHHHHHH
52.8621925322
35GlutarylationKKRKRSRKESYSVYV
CCCCCCCHHHHHHHH
52.8631542297
35OtherKKRKRSRKESYSVYV
CCCCCCCHHHHHHHH
52.8627105115
35SuccinylationKKRKRSRKESYSVYV
CCCCCCCHHHHHHHH
52.8619608861
35UbiquitinationKKRKRSRKESYSVYV
CCCCCCCHHHHHHHH
52.8623000965
37PhosphorylationRKRSRKESYSVYVYK
CCCCCHHHHHHHHHH
26.2423401153
38PhosphorylationKRSRKESYSVYVYKV
CCCCHHHHHHHHHHH
11.8421082442
39PhosphorylationRSRKESYSVYVYKVL
CCCHHHHHHHHHHHH
19.0925159151
41PhosphorylationRKESYSVYVYKVLKQ
CHHHHHHHHHHHHHH
7.6627155012
43PhosphorylationESYSVYVYKVLKQVH
HHHHHHHHHHHHHHC
4.2527273156
44UbiquitinationSYSVYVYKVLKQVHP
HHHHHHHHHHHHHCC
30.9221890473
44AcetylationSYSVYVYKVLKQVHP
HHHHHHHHHHHHHCC
30.9230779545
44GlutarylationSYSVYVYKVLKQVHP
HHHHHHHHHHHHHCC
30.9231542297
44LactoylationSYSVYVYKVLKQVHP
HHHHHHHHHHHHHCC
30.9231645732
44MethylationSYSVYVYKVLKQVHP
HHHHHHHHHHHHHCC
30.92-
44OtherSYSVYVYKVLKQVHP
HHHHHHHHHHHHHCC
30.9224681537
44UbiquitinationSYSVYVYKVLKQVHP
HHHHHHHHHHHHHCC
30.9223000965
47UbiquitinationVYVYKVLKQVHPDTG
HHHHHHHHHHCCCCC
53.9421890473
47AcetylationVYVYKVLKQVHPDTG
HHHHHHHHHHCCCCC
53.9419608861
47GlutarylationVYVYKVLKQVHPDTG
HHHHHHHHHHCCCCC
53.9431542297
47MethylationVYVYKVLKQVHPDTG
HHHHHHHHHHCCCCC
53.94-
47OtherVYVYKVLKQVHPDTG
HHHHHHHHHHCCCCC
53.9424681537
47SumoylationVYVYKVLKQVHPDTG
HHHHHHHHHHCCCCC
53.9419608861
47UbiquitinationVYVYKVLKQVHPDTG
HHHHHHHHHHCCCCC
53.9427667366
53PhosphorylationLKQVHPDTGISSKAM
HHHHCCCCCCCHHHH
40.6530266825
56PhosphorylationVHPDTGISSKAMGIM
HCCCCCCCHHHHHHH
27.4223401153
57PhosphorylationHPDTGISSKAMGIMN
CCCCCCCHHHHHHHH
23.6330266825
58"N6,N6-dimethyllysine"PDTGISSKAMGIMNS
CCCCCCHHHHHHHHH
35.29-
58AcetylationPDTGISSKAMGIMNS
CCCCCCHHHHHHHHH
35.29163977
58MethylationPDTGISSKAMGIMNS
CCCCCCHHHHHHHHH
35.29-
58OtherPDTGISSKAMGIMNS
CCCCCCHHHHHHHHH
35.2924681537
58UbiquitinationPDTGISSKAMGIMNS
CCCCCCHHHHHHHHH
35.2921906983
60SulfoxidationTGISSKAMGIMNSFV
CCCCHHHHHHHHHHH
4.2628183972
63SulfoxidationSSKAMGIMNSFVNDI
CHHHHHHHHHHHHHH
2.5928183972
65PhosphorylationKAMGIMNSFVNDIFE
HHHHHHHHHHHHHHH
17.1222617229
73MethylationFVNDIFERIAGEASR
HHHHHHHHHHHHHHH
17.20-
79PhosphorylationERIAGEASRLAHYNK
HHHHHHHHHHHHHCC
24.4322617229
80MethylationRIAGEASRLAHYNKR
HHHHHHHHHHHHCCC
42.83-
84PhosphorylationEASRLAHYNKRSTIT
HHHHHHHHCCCCCCC
19.4425884760
86"N6,N6,N6-trimethyllysine"SRLAHYNKRSTITSR
HHHHHHCCCCCCCHH
40.33-
86AcetylationSRLAHYNKRSTITSR
HHHHHHCCCCCCCHH
40.3319608861
86LactoylationSRLAHYNKRSTITSR
HHHHHHCCCCCCCHH
40.3331645732
86MethylationSRLAHYNKRSTITSR
HHHHHHCCCCCCCHH
40.33-
86OtherSRLAHYNKRSTITSR
HHHHHHCCCCCCCHH
40.3327105115
86UbiquitinationSRLAHYNKRSTITSR
HHHHHHCCCCCCCHH
40.3327667366
87MethylationRLAHYNKRSTITSRE
HHHHHCCCCCCCHHH
35.08-
88PhosphorylationLAHYNKRSTITSREI
HHHHCCCCCCCHHHH
26.2730266825
89PhosphorylationAHYNKRSTITSREIQ
HHHCCCCCCCHHHHH
32.1030266825
91PhosphorylationYNKRSTITSREIQTA
HCCCCCCCHHHHHHH
23.0930266825
92PhosphorylationNKRSTITSREIQTAV
CCCCCCCHHHHHHHH
24.8623401153
93MethylationKRSTITSREIQTAVR
CCCCCCHHHHHHHHH
36.07-
97PhosphorylationITSREIQTAVRLLLP
CCHHHHHHHHHHHCC
32.5523403867
100MethylationREIQTAVRLLLPGEL
HHHHHHHHHHCCHHH
19.70-
109UbiquitinationLLPGELAKHAVSEGT
HCCHHHHHHHHHHHC
44.7321890473
109SumoylationLLPGELAKHAVSEGT
HCCHHHHHHHHHHHC
44.73-
109AcetylationLLPGELAKHAVSEGT
HCCHHHHHHHHHHHC
44.73163953
109GlutarylationLLPGELAKHAVSEGT
HCCHHHHHHHHHHHC
44.7331542297
109LactoylationLLPGELAKHAVSEGT
HCCHHHHHHHHHHHC
44.7331645732
109MethylationLLPGELAKHAVSEGT
HCCHHHHHHHHHHHC
44.73-
109NeddylationLLPGELAKHAVSEGT
HCCHHHHHHHHHHHC
44.7332015554
109OtherLLPGELAKHAVSEGT
HCCHHHHHHHHHHHC
44.7324681537
109SumoylationLLPGELAKHAVSEGT
HCCHHHHHHHHHHHC
44.73-
109UbiquitinationLLPGELAKHAVSEGT
HCCHHHHHHHHHHHC
44.7321906983
113O-linked_GlycosylationELAKHAVSEGTKAVT
HHHHHHHHHHCHHHH
30.96UniProtKB CARBOHYD
113PhosphorylationELAKHAVSEGTKAVT
HHHHHHHHHHCHHHH
30.9628176443
116PhosphorylationKHAVSEGTKAVTKYT
HHHHHHHCHHHHHHC
16.2720068231
117UbiquitinationHAVSEGTKAVTKYTS
HHHHHHCHHHHHHCC
52.2821890473
117SumoylationHAVSEGTKAVTKYTS
HHHHHHCHHHHHHCC
52.28-
117AcetylationHAVSEGTKAVTKYTS
HHHHHHCHHHHHHCC
52.2822389435
117GlutarylationHAVSEGTKAVTKYTS
HHHHHHCHHHHHHCC
52.2831542297
117LactoylationHAVSEGTKAVTKYTS
HHHHHHCHHHHHHCC
52.2831645732
117MalonylationHAVSEGTKAVTKYTS
HHHHHHCHHHHHHCC
52.2822389435
117MethylationHAVSEGTKAVTKYTS
HHHHHHCHHHHHHCC
52.28-
117NeddylationHAVSEGTKAVTKYTS
HHHHHHCHHHHHHCC
52.2832015554
117OtherHAVSEGTKAVTKYTS
HHHHHHCHHHHHHCC
52.2827105115
117SuccinylationHAVSEGTKAVTKYTS
HHHHHHCHHHHHHCC
52.2822389435
117SumoylationHAVSEGTKAVTKYTS
HHHHHHCHHHHHHCC
52.2822389435
117UbiquitinationHAVSEGTKAVTKYTS
HHHHHHCHHHHHHCC
52.2823000965
120PhosphorylationSEGTKAVTKYTSSK-
HHHCHHHHHHCCCC-
24.1620068231
121UbiquitinationEGTKAVTKYTSSK--
HHCHHHHHHCCCC--
39.6721890473
121SumoylationEGTKAVTKYTSSK--
HHCHHHHHHCCCC--
39.67-
121AcetylationEGTKAVTKYTSSK--
HHCHHHHHHCCCC--
39.67163839
121GlutarylationEGTKAVTKYTSSK--
HHCHHHHHHCCCC--
39.6731542297
121LactoylationEGTKAVTKYTSSK--
HHCHHHHHHCCCC--
39.6731645732
121NeddylationEGTKAVTKYTSSK--
HHCHHHHHHCCCC--
39.6732015554
121OtherEGTKAVTKYTSSK--
HHCHHHHHHCCCC--
39.6727105115
121SuccinylationEGTKAVTKYTSSK--
HHCHHHHHHCCCC--
39.6722389435
121SumoylationEGTKAVTKYTSSK--
HHCHHHHHHCCCC--
39.6722389435
121UbiquitinationEGTKAVTKYTSSK--
HHCHHHHHHCCCC--
39.6727667366
122PhosphorylationGTKAVTKYTSSK---
HCHHHHHHCCCC---
11.50-
123PhosphorylationTKAVTKYTSSK----
CHHHHHHCCCC----
28.2524719451
124PhosphorylationKAVTKYTSSK-----
HHHHHHCCCC-----
32.8027251275
126AcetylationVTKYTSSK-------
HHHHCCCC-------
65.217431069
126NeddylationVTKYTSSK-------
HHHHCCCC-------
65.2132015554
126UbiquitinationVTKYTSSK-------
HHHHCCCC-------
65.2123000965

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
15SPhosphorylationKinaseMST1P26927
Uniprot
15SPhosphorylationKinaseSTK4Q13043
GPS
37SPhosphorylationKinaseAMPKQ9Y478
Uniprot
37SPhosphorylationKinaseAKT1P31749
PSP
79SPhosphorylationKinaseAURKBQ96GD4
GPS
84YPhosphorylationKinaseAURKBQ96GD4
GPS

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
4KMethylation

24681537
4KMethylation

24681537
4Kubiquitylation

24681537
4Kubiquitylation

24681537
15SPhosphorylation

12757711
15SPhosphorylation

12757711
35KMethylation

21925322
35Kubiquitylation

21925322
37SPhosphorylation

12757711
79KMethylation

-
79KMethylation

-
79Kubiquitylation

-
79Kubiquitylation

-
113Subiquitylation

-
121Kubiquitylation

16307923
121Kubiquitylation

16307923
121KMethylation

16307923

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of H2B2F_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions

Oops, there are no PPI records of H2B2F_HUMAN !!

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of H2B2F_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-6; LYS-17 AND LYS-21, ANDMASS SPECTROMETRY.
"Substrate and functional diversity of lysine acetylation revealed bya proteomics survey.";
Kim S.C., Sprung R., Chen Y., Xu Y., Ball H., Pei J., Cheng T.,Kho Y., Xiao H., Xiao L., Grishin N.V., White M., Yang X.-J., Zhao Y.;
Mol. Cell 23:607-618(2006).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-6; LYS-12; LYS-13; LYS-16;LYS-17; LYS-21; LYS-24 AND LYS-109, AND MASS SPECTROMETRY.
"Inhibition of core histones acetylation by carcinogenic nickel(II).";
Golebiowski F., Kasprzak K.S.;
Mol. Cell. Biochem. 279:133-139(2005).
Cited for: ACETYLATION AT LYS-6; LYS-13; LYS-16 AND LYS-21.
Phosphorylation
ReferencePubMed
"Apoptotic phosphorylation of histone H2B is mediated by mammaliansterile twenty kinase.";
Cheung W.L., Ajiro K., Samejima K., Kloc M., Cheung P., Mizzen C.A.,Beeser A., Etkin L.D., Chernoff J., Earnshaw W.C., Allis C.D.;
Cell 113:507-517(2003).
Cited for: PHOSPHORYLATION AT SER-15.
Ubiquitylation
ReferencePubMed
"Histone H2B monoubiquitination functions cooperatively with FACT toregulate elongation by RNA polymerase II.";
Pavri R., Zhu B., Li G., Trojer P., Mandal S., Shilatifard A.,Reinberg D.;
Cell 125:703-717(2006).
Cited for: UBIQUITINATION AT LYS-121.
"Monoubiquitination of human histone H2B: the factors involved andtheir roles in HOX gene regulation.";
Zhu B., Zheng Y., Pham A.-D., Mandal S.S., Erdjument-Bromage H.,Tempst P., Reinberg D.;
Mol. Cell 20:601-611(2005).
Cited for: UBIQUITINATION AT LYS-121.

TOP